Dr. Wallace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8630 Turners Bay Place
Anacortes, WA 98221Phone+1 407-920-3838
Education & Training
Naval Medical Center (San Diego)Fellowship, Infectious Disease, 1987 - 1989
University of WashingtonResidency, Internal Medicine, 1982 - 1984
University of Vermont Medical CenterInternship, Internal Medicine, 1981 - 1982
Saint Louis University School of MedicineClass of 1981
Certifications & Licensure
WA State Medical License 1983 - 2026
FL State Medical License 2005 - 2018
CA State Medical License 1985 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Jay Sanford Award Armed Forces ID Society, 2011
Publications & Presentations
PubMed
- 105 citationsRed Man Syndrome: Incidence, Etiology, and ProphylaxisMark R. Wallace, John R. Mascola, Edward C. Oldfield
The Journal of Infectious Diseases. 1991-12-01 - 367 citationsComparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.Nancy F. Crum, Robert H. Riffenburgh, Scott Wegner, Brian K. Agan, Sybil A. Tasker
Journal of Acquired Immune Deficiency Syndromes. 2006-02-01 - 56 citationsA review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management.Nancy F. Crum, Kari Furtek, Patrick E. Olson, Christopher L. Amling, Mark R. Wallace
AIDS Patient Care and Stds. 2005-10-18
Press Mentions
Travecta Therapeutics Appoints Leading Experts to Expand Its Scientific Advisory Leadership TeamFebruary 15th, 2022- CORBEVAX®, a COVID19 Vaccine Developed by Bio E-india Based on the RBD Protein Antigen Technology from Texas Children's Hospital Center for Vaccine Development, Receives World Health Organization Emergency Use Listing ApprovalJanuary 23rd, 2024
Professional Memberships
- Fellow
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
